MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2018 International Congress

    Comparison of Treatment Effectiveness of Conventional Functional Training (CFT) to Occupational Therapy (OT) Multi-modal CASH Program (CASH) in Improving Non-motor Symptoms and Carer Stress of Parkinson’s (PD) Patient at Intermediate and Advanced State

    T. Tang, R. Wong, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong)

    Objective: This study is a prospective pilot study to investigate the effectiveness of OT 'CASH' group therapy on intermediate and advanced PD patients in managing…
  • 2018 International Congress

    Dyspnea in Parkinson’s disease: A biomarker of disease’s severity?

    G. Baille, T. Perez, F. Machuron, L. Defebvre, C. Chenivesse, C. Moreau (Lille, France)

    Objective: The aim of our study was to determine the prevalence of dyspnea in a monocentric cohort of 153 non-demented PD patients (mean age: 63.9…
  • 2018 International Congress

    Prefrontal cortical stimulation to treat anxiety and depression in Parkinson’s disease

    C. de Hemptinne, W. Chen, C. Racine, A. Seritan, A. Miller, J. Mergenthaler, S. Rajagopalan, J. Ostrem, M. San Luciano, P. Starr (San Francisco, CA, USA)

    Objective: The aims of this study are 1) to study the neurophysiology underlying anxiety and depression in PD patients, and 2) to determine whether cortical…
  • 2018 International Congress

    Measuring salivary cortisol levels in persons with Parkinson’s disease (PD)

    A. Hiller, B. Lobb, J. Proulx, J. Quinn (Portland, OR, USA)

    Objective: To better characterize the relationship between salivary cortisol and psychological stress in persons with Parkinson’s disease (PD). Background: Psychological stress is known to exacerbate…
  • 2018 International Congress

    A Preliminary Study of Cinnamomum verum on Anxiety, Locomotor Activity and Emotionality Behaviour in Wistar Albino Rats

    N. Ahmed (Aligarh, India)

    Objective: Introduction: Cinnamomum verum is a very common traditional Indian Spice known as Darchini. It is obtained from the inner bark of several species of…
  • 2018 International Congress

    Parkinson’s disease anxiety is associated with Lewy bodies in the Anterior Cingulate

    N. Fischer, J. Hinkle, K. Perepezko, G. Pontone (Baltimore, MD, USA)

    Objective: The goal of this study is to determine if there is an association between anxiety and the presence and regional distribution of Lewy bodies…
  • 2018 International Congress

    Effect of mindfulness yoga on psychological distress in people with Parkinson’s disease (PD): A randomized controlled trial

    J.Y.Y. Kwok, J.C.Y. Kwan, M. Auyeung, C.T. Mok, C.K.Y. Lau, H.Y.L. Chan (New Territories, Hong Kong)

    Objective: To determine the effects of yoga versus conventional stretching and resistance training exercises (SRTE) on psychological, physical, spiritual, and health-related quality-of-life (HRQOL) outcomes among…
  • 2018 International Congress

    Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson’s disease

    H.J. Yang, B.S. Park, J.Y. Park, E.M. Lee, S.Y. Kim, W.J. Kim, J.H. Kwon (Ulsan, Republic of Korea)

    Objective: We aim to assess the psychometric properties of the Korean version of Hospital Anxiety and Depression Scale (HADS) in a sample of early-stage Parkinson's…
  • 2018 International Congress

    Is there a relationship between depression/anxiety and physical inactivity in Parkinson Disease?

    B. Aktar, B. Balci, B. Donmez Colakoglu (Izmir, Turkey)

    Objective: To investigate the relationships between depression/anxiety and activity limitations in Parkinson disease (PD). Background: Depression, anxiety are common non-motor symptoms in PD. Depression which…
  • 2018 International Congress

    Assessment of cognitive functions, depression-anxiety scales and quality of life in patients and their relatives with Cervical Dystonia and Botulinum Toxin Treatment

    D. Ceylan, S. Erer, M. Zarifoglu, N. Turkes, A. Demiralay (Bursa, Turkey)

    Objective: In this study, we investigated the psychiatric comorbid disorders and quality of life issues such as cognitive dysfunction accompanied by cervical dystonia and accompanying…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley